$PATHBullishMed

UiPath (NYSE:PATH) Beats Q1 CY2026 Sales Expectations

UiPath (NYSE:PATH) reported Q1 CY2026 revenue of $418.4 million, up 17.3% year on year and 5.2% above analysts’ estimates, according to the company. Non-GAAP profit was $0.15 per share, in line with consensus. UiPath guided next-quarter revenue to about $397.5 million. The stock fell 1.4% to $11.57 after results.

9/10
8/10
Med
Bullish
after-hours / post-results reaction (stock down 1.4% to $11.57 immediately following results)
Supports a modestly positive fundamental read-through, but market reaction was slightly negative, implying sensitivity to billings/ARR quality.

Beat on revenue and in-line EPS with next-quarter revenue near consensus, but ARR growth and billings softness raise quality concerns.

UiPath reported Q1 CY2026 revenue of $418.4M (+17.3% YoY), beating estimates, and guided next-quarter revenue to ~$397.5M.

Near-term downside risk if investors focus on billings miss and slower ARR growth despite the headline beat.

Background

UiPath is an automation software provider (RPA evolving into broader AI-powered business automation). The piece frames the quarter using both reported revenue and subscription-style ARR, plus customer acquisition efficiency (CAC payback).

Why it matters

Headline revenue beat and in-line non-GAAP EPS are offset by concerns about billings and slower ARR growth, suggesting investors may re-rate the stock based on revenue quality rather than topline momentum alone.

Market relevance

Material earnings-style datapoints (revenue beat, EPS in-line, next-quarter guide) with explicit follow-through concerns (billings miss, slower ARR growth) drive the trading narrative.

Market effects

Reinforces that enterprise automation/RPA demand may be decelerating, with investors scrutinizing recurring revenue quality (ARR) vs. one-off services.

Primarily US-listed software sentiment; limited direct regional spillover beyond growth-software complex.

Automation software demand signals can influence global SaaS/automation peers’ read-across, though the article is single-name focused.

Alternative perspectives

The revenue beat plus next-quarter guide near consensus may be enough to stabilize sentiment even if billings/ARR growth are softer.

The article notes CAC payback improvement (30.8 months), which could support future growth efficiency despite slower ARR growth.

Key entities

  • UiPath

    Reported Q1 CY2026 revenue beat and provided next-quarter revenue guidance; also discussed ARR growth and CAC payback.

Related articles

$PATHMedAI 9/10

Stock Market Today, June 1: Stock Market Today, June 1: UiPath Rises After Strong Q1 Results and Raised Outlook

UiPath (NYSE:PATH) rose 11.77% to close at $13.10 after reporting fiscal Q1 2027 results and raising guidance, according to the company. The report cited 17% year-over-year revenue growth to $418 million, annual recurring revenue of $1.901 billion (+12%), and positive GAAP operating income of $28 million. Trading volume was 65.5 million shares.

$ESTCMedAI 9/10

Morgan Stanley slashes targets on 3 software stocks after earnings

Morgan Stanley cut price targets on Elastic, UiPath and PagerDuty after their earnings, citing uneven AI impact across software. For Elastic, it kept Equal Weight and lowered the target to $73 from $80; Q4 remaining performance obligations rose 20% to $1.2B and RPO 27% to $1.98B. For UiPath, target fell to $15 from $17; FY2027 ARR guidance was $2.058B–$2.063B. PagerDuty target was cut to $7 from $10.

$DELLMedAI 8/10

Hardware's back: AI supercharges server, PC and memory sales

The article says AI demand is boosting enterprise hardware and related software. Dell’s revenue jumped 88% and its stock rose 31% on AI server sales, while NetApp and HP also benefited. Micron and SK hynix each passed $1 trillion market caps on AI memory demand. Snowflake shares rose 36% after strong earnings and an AWS compute deal.

$PATHMedAI 8/10

UiPath (NYSE:PATH) Issues Earnings Results

UiPath reported quarterly EPS of $0.15, matching analysts’ consensus, and revenue of $418.38 million versus a $397.54 million estimate, according to FiscalAI. The company posted a 17.53% net margin and 5.69% return on equity. Shares rose to $11.60 mid-day. Analysts’ targets range from $13 to $14, with a consensus $14.07.

$PATHMedAI 9/10

UiPath Stock Rises Ahead Of Q1 Earnings: What Traders Should Watch - UiPath (NYSE:PATH)

UiPath (NYSE:PATH) shares rose about 3% before first-quarter results after the close, according to Benzinga Pro. Analysts expect EPS of 13 cents and revenue of $397.47M. In the prior quarter, UiPath reported EPS of 30 cents and revenue of $481.11M, both above consensus. The company said it is focused on expanding platform adoption and operating discipline as fiscal 2027 begins.